Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.32 |
| ▸ | CASP3 | P42574 | 2/20 | 0.32 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.32 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.32 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17485425 | 0.91 | RAB9A (0.39) | NPC1RAB9ASMN1; SMN2HTTCASP3 | |
| SCHEMBL23084630 | 0.90 | NPC1 (0.35) | NPC1RAB9ASMN1; SMN2HTTCASP3 | |
| SCHEMBL24496166 | 0.87 | KCNH2 (0.36) | NPC1RAB9ASMN1; SMN2HTTCASP3 | |
| SCHEMBL22651406 | 0.86 | ELANE (0.38) | NPC1RAB9ASMN1; SMN2HTTCASP3 | |
| SCHEMBL22651234 | 0.84 | RAB9A (0.38) | NPC1RAB9ASMN1; SMN2HTTCASP3 | |
| SCHEMBL24604432 | 0.84 | NPC1 (0.35) | NPC1RAB9ASMN1; SMN2HTTCASP3 | |
| SCHEMBL23698605 | 0.84 | HTT (0.35) | NPC1RAB9ASMN1; SMN2HTTCASP3 | |
| SCHEMBL23061476 | 0.83 | HTT (0.37) | NPC1RAB9ASMN1; SMN2HTTCASP3 | |
| SCHEMBL24604442 | 0.83 | RAB9A (0.36) | NPC1RAB9ASMN1; SMN2HTTCASP3 | |
| SCHEMBL25657151 | 0.82 | NPC1 (0.39) | NPC1RAB9ASMN1; SMN2HTTCASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220213099-A1 | PRODRUG COMPOUNDS | BRISTOL MYERS SQUIBB CO (US) | 2022-07-07 | — | — | US | disclosed |
| WO-2020227337-A1 | PRODRUG COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213099-A1 | PRODRUG COMPOUNDS | TLR7, TLR4, TLR9 | NPC1 2879/4885RAB9A 776/4885SMN1; SMN2 4232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.